This randomised controlled trial compared the effect of equipotent anaesthetic doses of sevoflurane (S group) versus propofol (P group), during remifentanil-based anaesthesia for off-pump coronary artery bypass surgery, on myocardial injury. Either sevoflurane or propofol was titrated to maintain bispectral index values between 40 and 50. In both groups, a targeted concentration of remifentanil 20 ng.ml -1 was maintained during anaesthesia. The concentrations of creatine kinase MB and troponin I were measured before the start of surgery, on admission to the intensive care unit, and at 12 and 24 hours after intensive care unit admission. The postoperative values of creatine kinase MB (S group: 15.08±18.97, 20.78±20.92, 12.76±12.82 vs 2.09±1.54 ng.ml -1 ; P group: 10.99±13.15, 27.16±56.55, 11.88±18.80 vs 1.84±1.67 ng.ml -1 ) and troponin I (S group: 3.56±5.19, 5.66±7.89, 3.35±4.55 vs 0.52±1.90 ng.ml -1 ; P group: 2.42±3.33, 4.11±6.01, 3.04±5.31 vs 0.43±1.28 ng.ml -1 ) were significantly higher than preoperative values in both groups but there were no significant differences between the two groups. There were no significant differences in time to extubation (S group, 476±284 minutes; P group, 450±268 minutes) and intensive care unit length of stay (S group, 2775±1449 minutes; P group, 2797±1534 minutes) between the two groups. In conclusion, sevoflurane and propofol at equipotent doses guided by bispectral index with remifentanil 20 ng.ml -1 had similar creatine kinase MB and troponin I values.
Volatile anaesthetic agents are reported to have cardioprotective properties. This is thought to be due to a preconditioning effect 1, 2 or a beneficial effect on the myocardial reperfusion injury 3, 4 , or both. The intravenous anaesthetic agent propofol is also reported to have cardioprotective properties. Postulated mechanisms include a direct effect on the myocardial calcium influx 5 or an inhibition of the mitochondrial permeability transition 6 , which is associated with a free radical scavenging effect 7 . These cardioprotective effects have been associated with less myocardial injury and shorter intensive care unit (ICU) stay after coronary artery bypass grafting (CABG) surgery. Some studies have demonstrated that volatile anaesthetic agents achieve better outcomes compared to intravenous anaesthetic agents after CABG [8] [9] [10] [11] . However, these studies did not confirm that an equipotent anaesthetic dose of each anaesthetic agent had been received.
We hypothesised that equipotent anaesthetic doses of volatile and intravenous anaesthetic agents would show the different outcomes when compared with previous studies [8] [9] [10] [11] . In our study, we compared the outcomes using doses of sevoflurane versus propofol, both adjusted to maintain the bispectral index (BIS) values between 40 and 50, during remifentanil-based anaesthesia for off-pump coronary artery bypass (OPCAB) surgery.
MATERIALS AND METHODS

Study population
After obtaining institutional review board approval and informed consent, this study was conducted in a prospective, single-blind and randomised fashion. Patients undergoing OPCAB surgery were enrolled.
Patients were excluded if any of the following criteria were present: 1) urgent or emergent case, 2) redo case, 3) preoperative dysrhythmia, 4) reduced left or right ventricular function (ejection fraction <40%), 5) significant valvular heart disease, 6) intracardiac shunt, 7) myocardial infarction or clinical angina within 14 days, 8) concurrent other surgery, 9) concurrent oral hypoglycaemic agents such as sulfonylurea derivatives (antagonist of K ATP [adenosine triphosphate-sensitive potassium] channels), nicorandil (agonist of K ATP channels), or theophylline (blocker of adenosine release), 10) severe renal disease (serum creatinine >2.0 mg.dl -1 ) and 11) severe hepatic disease.
The patients were randomised to receive either sevoflurane-remifentanil (S group) or propofolremifentanil (P group) for anaesthesia using sealed envelopes before anaesthesia induction. Either sevoflurane or propofol was prepared by nurses who were not involved in the study, according to the results of sealed envelopes. Cardiac surgeons, and physicians and nurses in the ICU were blinded to the allocation group. All data were collected by trained observers who did not participate in patient care and who were blinded to the anaesthetic regimen.
Anaesthetic technique
The anaesthetic technique was standardised. The patient arrived at the operation room without premedication. After establishing routine invasive systemic arterial blood pressure monitoring and noninvasive patient monitoring (pulse oximetry, electrocardiography, cerebral oximetry and BIS [VISTA™, A Bispectral Index™ Monitor, Aspect Medical Systems, Norwood, USA]), anaesthesia was induced with etomidate 0.1 mg.kg -1 . After confirming a loss of consciousness, rocuronium 0.5 mg.kg -1 was administered. The patients received either sevoflurane or propofol, with remifentanil.
In the S group, an initial end-expiratory concentration of sevoflurane 1.0% was administered with a vaporiser (Aladin™, Datex-Ohmeda Division Instrumentarium AB, Bromma, Sweden) and maintained for 10 minutes. The inspiratory and expiratory concentrations of sevoflurane were measured using a gas analyser (S/5™ Compact Anaesthesia Monitor, Datex-Ohmeda, Finland). The maximal and minimal end-expiratory concentrations of sevoflurane were recorded during anaesthesia. In the P group, an initial target concentration of propofol 1 µg.ml -1 was administered and maintained for 10 minutes using a target-controlled infusion (Orchestra ® Base Primea, Fresenius Vial, Brezins, France). The maximal and minimal target concentrations of propofol were recorded during anaesthesia. The end-expiratory concentration of sevoflurane and the target concentration of propofol were titrated at a high and low of 0.1%.ml -1 and 0.1 µg.ml -1 respectively, to maintain BIS values between 40 and 50. In both groups, remifentanil was administered slowly using a target-controlled infusion. The target concentration of 20 ng.ml -1 was achieved after 10 minutes of administration and maintained during the procedure.
After the induction of anaesthesia, patients were ventilated with 40% oxygen in air. The tidal volume was 8 ml.kg -1 (lean body mass) and positive endexpiratory pressure was not utilised. The respiratory rate was adjusted to keep the partial pressure of end-tidal carbon dioxide between 35 and 40 mmHg. A pulmonary artery catheter (Swan-Ganz CCOmbo CCO/SvO 2 ® , Edwards Lifesciences, Irvine, USA) was inserted into the right internal jugular vein. Transoesophageal echocardiography was routinely performed. Additional rocuronium was administered under the guidance of peripheral monitoring of neuromuscular transmission.
Off-pump coronary artery bypass surgery
All procedures were performed by the same surgeon using the same technique. Anticoagulation was provided by intravenous heparin after graft harvesting and the activating clotting time was maintained above 300 seconds during revascularisations. A mechanical stabiliser (Octopus, Medtonic, Minneapolis, USA) and a heart positioner (Starfish, Medtonic, Minneapolis, USA) were used to control the motion of the beating heart. Intravenous protamine was administered slowly to reverse the anticoagulation after revascularisation. At the end of surgery, the study drug was stopped and remifentanil 10 ng.ml -1 was continuously infused for 60 minutes.
Protocols of extubation and discharge from the ICU 9
Medical treatment and decision making in the ICU were performed by physicians who were blinded to the allocation group. The extubation regimen was started when the following criteria were met: haemodynamically stable, urine output ≥0.5 ml.kg -1 .hour -1 , temperature >36°C and chest tube drainage <100 ml.hour -1 . Patients received morphine 0.2 mg.kg -1 approximately 45 minutes prior to extubation. The patients were assessed for their vital signs, pain and sedation. An additional bolus of morphine 5 mg was administered if the patients experienced pain. The patients were extubated when the following criteria were achieved: adequate response to command, adequate respiratory efforts, oxygen saturation measured by pulse oximetry ≥95% at a fraction of inspired oxygen of ≤0.5, pH ≥7.3 and an arterial partial pressure of carbon dioxide of ≤55 mmHg.
The patients were eligible for transfer from the ICU when the following criteria were met: adequate cardiac stability with no haemodynamically significant arrhythmia, pulse oximetry ≥90% at a fraction of inspired oxygen of ≤0.5 (by a face mask), urine output >0.5 ml.kg -1 .hour -1 , chest tube drainage <50 ml.hour -1 , no intravenous inotropic or vasopressor therapy and no seizure activity.
The time to extubation was defined as the time from arrival at the ICU to extubation. The ICU length of stay (LOS) was defined as the time from arrival at the ICU to satisfy the ICU discharge criteria.
Cardiac markers
In all patients, blood was sampled to determine creatine kinase MB (CK-MB) and troponin I (TnI) concentrations. These samples were obtained before the start of surgery (T0), on admission to the ICU (T1), and at 12 hours (T2) and 24 hours (T3) after ICU admission.
Statistics
From a pilot study with 12 OPCAB surgery patients including the S group (six patients) and the P group (six patients), a TnI of 0.60±0.51 ng.ml -1 , time to extubation of 423±157 minutes and ICU LOS of 2326±744 minutes were found. The primary outcome variable was myocardial injury, evaluated by TnI. A minimum detected difference of TnI 0.3 ng.ml -1 between the groups was considered to be of clinical significance. The sample size of 47 for TnI in each group were calculated with a power of 0.8 and an α value of 0.05. Secondary outcome variables were time to extubation and ICU LOS. A minimum detected difference of 120 minutes for time to extubation time and a minimum detected difference of 720 minutes for ICU LOS between the groups was considered to be of clinical significance. The sample sizes of 28 for time to extubation time and 18 for ICU length of stay in each group were calculated with a power of 0.8 and an α value of 0.05.
The data were analysed using the program Statistical Package for the Social Sciences v. 11.0 (SPSS Inc., Chicago, USA). The intragroup changes in the cardiac markers over time were analysed using an analysis of the variance on ranks for repeated measurements (Friedmann) and, if significant, a Tukey's test was performed to compare the variables with the baseline value. The values between two groups were analysed using an unpaired chi square test, Fisher's exact test or Mann-Whitney Rank Sum test. All data are expressed as the number of patients or mean ± standard deviation. A value of P <0.05 was considered statistically significant.
RESULTS
Ninety-four patients (S group: 47, P group: 47) were studied. The patients' demographic and clinical characteristics were similar in both groups (Table 1 ). There were no significant differences in the harvesting and revascularised vessels ( Table 2) . The minimal and maximal end-tidal concentrations of sevoflurane to maintain BIS values between 40 and 50 were 0.9% (95% confidence interval [CI] 0.36 to 1.35%) and 1.2% (95% CI 0.48 to 1.82%), at T3 versus 0.43±1.28 at T0 in the P group) were significantly higher than the preoperative value in both groups, whereas there were no significant differences between the two groups ( Table 3 and Figure 1 ). There were no significant differences in the time to extubation (476±284 minutes in the S group versus 450±268 minutes in the P group) and ICU LOS (2775±1449 minutes in the S group versus 2797±1534 minutes in the P group) between the two groups ( Table 4 ). 
DISCUSSION
Our results show that the degree of myocardial injury, time to extubation and ICU LOS were similar in the S and P groups.
Several previous studies showed that volatile anaesthetic agents produced better outcomes than intravenous anaesthetic agents in terms of myocardial injury (De Hert et al, sevoflurane 0.5 to 2% versus propofol 2 to 4 µg.ml -1 [target concentration] 8-10 ; Bein B et al, sevoflurane 1 minimum alveolar concentration [MAC] versus propofol 3 to 4 mg.kg -1 .hour -1 11 ). However, these sevoflurane and propofol concentrations could not guarantee the same anaesthetic depth. Specifically, they were not equipotent anaesthetic doses.
In the present study, equipotent doses of sevoflurane and propofol were designated as the same hypnotic or sedative level, defined by BIS values between 40 and 50. The BIS was monitored continuously and maintained between 40 and 50 in both groups to allow a comparison of the effects of equipotent anaesthetic doses of sevoflurane and propofol. BIS, as a pharmacodynamic endpoint, provides a basis for rational clinical comparisons between volatile and intravenous anaesthetic agents 12 . Targeting anaesthesia to BIS decreases consumption of sevoflurane and propofol, and facilitates immediate recovery after anaesthesia, whereas intraoperative courses are not changed 13 . When anaesthetic depth was adjusted by target BIS values below 60, sevoflurane and propofol showed no differences of postoperative conditions in caesarean section 14 . BIS was used for adjustment of equivalent doses of sevoflurane and propofol in several studies [14] [15] [16] [17] [18] . The BIS values between 40 and 50 for control of anaesthetic depth could be debated, but are the usual range found in clinical studies and recommended range by the manufacturers 19 .
Law-Koune et al compared the myocardial protective potentials, as assessed by the postoperative TnI between sevoflurane-remifentanil versus propofol-remifentail anaesthesia in patients undergoing OPCAB surgery, using BIS values between 40 and 60 to compare equipotent doses. Their study showed no significant differences between the two groups 18 . However, the remifentanil concentration was greater in the propofol-remifentanil group than the sevoflurane-remifentanil during the maximal sternal spread, during preparation of the first graft, after completing the first graft, during preparation of the second graft, and after completing the second graft. The difference in remifentanil concentration could affect the cardioprotective effects of sevoflurane and propofol. Remifentanil also has a cardioprotective effect, even though it is difficult to extrapolate the dose for the studies from small animal (rat) models to humans 20, 21 . Opioid receptors appear to be involved in cardiovascular regulation [22] [23] [24] and several studies have found that the activation of certain opioid receptors can induce a cardioprotective effect similar to classic and delayed ischaemic preconditioning [25] [26] [27] . The cardioprotective effect of remifentanil is mediated via three opioid receptors, the µ-, γand δ-opioid receptors 20, 21 . The target concentration of remifentanil 20 ng.ml -1 in the present study was higher than the concentrations of remifentanil (0.3 to 0.6 µg.kg -1 .minute -1 8-10 and 0.3 µg.kg -1 .minute -1 11 ) in studies showing that volatile anaesthetic agents have better outcomes than intravenous anaesthetic agents. Higher remifentanil doses could decrease the level of cardiac damage and result in a shorter time to extubation and ICU LOS. Propofol requirements decrease with increasing remifentanil concentrations 28 . The higher remifentanil dose in the present study reduced the requirements of propofol (>50%), which could have affected the outcomes. The concentration of propofol (0.8±0.2 to 1.4±0.2 µg.ml -1 ) in the present study was lower than the concentration of propofol (2 to 4 µg.ml -1 8-10 and 3 to 4 mg.kg -1 .hour -1 11 ) in investigations showing that volatile anaesthetic agents have better outcomes than intravenous anaesthetic agents.
However, there was one important consideration: whether the sevoflurane concentration in our study was adequate for cardioprotection. The appropriate sevoflurane concentration for cardioprotection is unclear. Preckel et al reported that that sevoflurane 1.5 MAC reduced the level of CK release and improved myocardial function 29 , and sevoflurane 1.0 MAC reduced the infarct size after regional myocardial ischaemia and reperfusion 3 . Obal et al reported that the administration of sevoflurane 1 MAC early during the reperfusion period reduced the infarct size. A lower concentration of 0.75 MAC apparently had no effect on the infarct size, whereas increasing the sevoflurane concentration to 2 MAC had a significant effect on the infarct size similar to 1 MAC 30 . Piriou et al reported that sevoflurane 1 MAC for 15 minutes did not have a significant preconditioning effect 31 . Investigations of various concentrations of sevoflurane and equipotent doses of propofol, guided by BIS, will be needed.
Experimental data showed that volatile anaesthetic agents offer protection against myocardial ischaemia when administered before an ischaemic insult 32, 33 , involving different biochemical pathways, such as the adenosine receptor, protein kinase, mitochondrial K ATP channel 34 , mitochondrial permeability transition pore opening 35 and mitogenactivated protein kinases 36 . Sulfonylurea derivatives, nicorandil and theophylline can affect the level of cardioprotection induced by both ischaemic and pharmacological preconditioning. Therefore patients who took sulfonylurea, nicorandil or theophylline were excluded.
The anaesthetic regimen can affect the outcomes after OPCAB surgery. De Hert et al reported that volatile anaesthetic agents produced a shorter ICU and hospital LOS than intravenous anaesthetic agents, and the shorter ICU and hospital LOS appeared to be related to the better preservation of the early postoperative myocardial function, as evaluated by the postoperative TnI 9 . No significant differences in postoperative cardiac markers were associated with no significant differences in the time to extubation and ICU LOS between the S and P groups in the present study.
In the present study, myocardial injury was assessed by CK-MB and TnI. The ideal cardiac markers for evaluation of myocardial injury need high sensitivity/specificity, rapid release (for early diagnosis) and long half-life in blood (for late diagnosis) after injury. CK-MB and cardiac troponins are commonly used for cardiac markers. CK-MB rises in parallel following myocardial injury, but also rises in skeletal muscle injuries. Consequently, CK-MB should not be used for evaluation of myocardial injury without combinations of other specific cardiac markers. Cardiac troponins are specific for the myocardium and are not expressed in skeletal muscle. Because of high sensitivity and specificity, cardiac troponins are useful for evaluation of myocardial injury. However, cardiac troponins persist in high concentration for a long period after initial injury and may be of no value in detecting re-injury. CK-MB, with its shorter time course, becomes more useful in assessing recurrent injury 37 . Both cardiac troponin T and I are appropriate as cardiac markers, but TnI has superior sensitivity and specificity, especially in patients with renal disease 38 . Cardiac troponins serve as better predictors of prognosis than CK-MB after CABG 39 . A high postoperative TnI is associated with poor prognosis 40 . Therefore, CK-MB and TnI were used for assessment of myocardial injury in the present study.
Our study had several limitations. First, exclusion criteria in the study were extensive, though they were not exceptional for comparison between volatile and intravenous anaesthetic agents 8, 9, 11, 12, 31 . Our extensive exclusion criteria might be associated with no differences of myocardial injury and postoperative outcomes. However, it is impossible to compare the myocardial injury between volatile and intravenous anaesthetic agents without verifying individual preoperative risk factors as have been suggested by Fortescue et al 41 . Therefore, strict exclusion criteria are required. Second, a minimum difference of TnI 0.3 ng.ml -1 between the groups was considered to be of clinical significance. It was a relative large difference. If a smaller difference were to be considered to be of clinical significance, a larger sample size would be needed, though several studies for comparison of myocardial injury between sevoflurane and propofol in CABG evaluated smaller sample sizes (each 9, 10, 22 or 36 patients) than our study 8, 11, 18, 31 . However, De Hert et al considered a minimal detected difference of TnI 2 ng.ml -1 to be of clinical significance [8] [9] [10] and Crescenzi et al reported that the lowest releases of TnI for undergoing OPCAB and CABG were 0.5 and 2.0 ng.ml -1 respectively 42 . If a minimal detected difference of TnI 2 or 0.5 ng.ml -1 was considered to be of clinical significance in the present study, the sample size of 3 or 18 in each group was calculated with a power of 0.8 and an α value of 0.05. Nevertheless, further studies with larger samples would help to support the present study.
Our randomised controlled trial found that when OPCAB surgery patients are anaesthetised with remifentanil 20 ng/ml -1 and either sevoflurane or propofol at equipotent doses (as determined by BIS), the choice of maintenance agent did not influence myocardial injury (as assessed by CK-MB and TnI), time to extubation, or length of ICU stay.
